Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization

Authors

Keywords

Journal

Volume 41, Issue 9, Pages 861-866

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2017-04-18

DOI

10.1097/coc.0000000000000384

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now